Cancer Prevention Research Clinical validation shows suppression of 70% of genes overexpressed in aggressive metastatic colon cancer, reduced tumor incidence, and enhanced immune surveillance capabilities
An innovative workshop, inspired by the Delphi method, was conducted to bring together experts, including scientists, associations, and industry representatives, to achieve a high level of consensus at every stage of the process
Third-party HPLC/MS tested with batch-specific COA documentation
Methods: PhEAST is a randomised, open-label, blinded-endpoint trial assessing pharyngeal electrical stimulation (PES) vs no PES
Its designed to heal and rebuild, not exfoliate